Neoplasm malignant: FDA reporting patterns
65,826 FDA FAERS reports mention Neoplasm malignant. 64,222 reports have a serious outcome flag.
Medicines named as suspect
- Ranitidine: 10,655 reports
- Adalimumab: 2,515 reports
- Etanercept: 2,058 reports
- Apixaban: 1,801 reports
- Infliximab: 1,638 reports
- Methotrexate: 1,126 reports
- Rituximab: 1,121 reports
- Valsartan: 1,117 reports
- Tofacitinib: 1,035 reports
- Risankizumab: 973 reports
- Zoledronic Acid: 973 reports
- Imatinib: 961 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.